SCND SCIENTIFIC INDUSTRIES INC

Scientific Industries to Host Third Quarter 2024 Financial Results Investor Call on November 15, 2024

Scientific Industries to Host Third Quarter 2024 Financial Results Investor Call on November 15, 2024

Investor Call to be held at 11:00 AM Eastern Time

BOHEMIA, N.Y., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Scientific Industries, Inc. (OTCQB: SCND), a life sciences tool provider, and a developer of digitally simplified bioprocessing products, announced today it plans file the Form 10Q on November 14, 2024, for its third quarter financial results ended September 30, 2024, and will issue a press release reporting its third quarter 2024 results before the market open on November 15, 2024.

The Company will conduct a conference call for all interested parties on Friday, November 15, at 11:00 a.m. Eastern Time to discuss its financial results.

Conference Call Details

To participate in this call, please dial (844) 481-2706 or (412) 317-0662 (international), or listen via a live webcast, which is available on the Company’s Investor Relations page at or at . A replay of the call will be available through November 22, 2024, at (877) 344-7529 or (412) 317-0088 (international), replay access code: 6861983, or for 30 days at .

About Scientific Industries, Inc.

Scientific Industries (OTCQB: SCND), is a life science tool provider. It designs, manufactures, and markets laboratory equipment, including the world-renowned Vortex-Genie® 2 Mixer and Torbal® balances, and bioprocessing systems under the product name DOTS. Scientific Industries’ products are generally used and designed for research purposes in laboratories of universities, hospitals, pharmaceutical companies, medical device manufacturers, and pharmacies. To learn more, visit .

About Scientific Bioprocessing, Inc.

Scientific Bioprocessing, Inc. (“SBI”) is dedicated to pioneering digitally simplified bioprocessing by providing actionable insights from lab to production floor. With a broad portfolio of state-of-the-art bioprocess sensors and actuators as well as innovative data analytics software, SBI helps scientists and engineers in bioprocessing to monitor and control critical process parameters and product quality attributes. SBI is a subsidiary of Scientific Industries Inc. (SCND-OTCQB) To learn more, visit .

Safe Harbor Statement

Statements made in this press release that relate to future events, performance or financial results of the Company are forward-looking statements which involve uncertainties that could cause actual events, performance or results to materially differ. The Company undertakes no obligation to update any of these statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as to the date hereof. Accordingly, any forward-looking statement should be read in conjunction with the additional information about risks and uncertainties set forth in the Company's Securities and Exchange Commission reports, including our annual report on Form 10-K.

Company Contact: 
Helena R. Santosor:  
CEO and PresidentJoe Dorame
Phone: 631-567-4700Lytham Partners, LLC
Phone: (602)889-9700


EN
12/11/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on SCIENTIFIC INDUSTRIES INC

 PRESS RELEASE

Scientific Industries Secures New Funding to Advance its SBI Bioproces...

Scientific Industries Secures New Funding to Advance its SBI Bioprocessing Division BOHEMIA, N.Y., April 22, 2025 (GLOBE NEWSWIRE) -- Scientific Industries, Inc. (OTCQB: SCND), a life sciences tool provider, and a developer of digitally simplified bioprocessing products, announced today that it has successfully secured approximately $1.6 million in a private placement to advance the Company’s SBI’s DOTS Platform, a real-time bioprocessing system and for general corporate use. The offering consisted of 1,550,000 shares of the Company’s common stock at a purchase price of $1.00 per share...

 PRESS RELEASE

Scientific Industries to Host Fiscal Year 2024 Financial Results Inves...

Scientific Industries to Host Fiscal Year 2024 Financial Results Investor Call on April 1, 2025 Investor Call to be held at 11:00 AM Eastern Time BOHEMIA, N.Y., April 01, 2025 (GLOBE NEWSWIRE) -- Scientific Industries, Inc. (OTCQB: SCND), a life sciences tool provider, and a developer of digitally simplified bioprocessing products, announced it filed the Form 10K and issued a press release on March 31, 2025, for its fiscal year financial results ended December 31, 2024. The Company will conduct a conference call for all interested parties on Tuesday, April 1, at 11:00 a.m. Eastern Ti...

 PRESS RELEASE

Scientific Industries Reports Financial Results for Fiscal Year Ended ...

Scientific Industries Reports Financial Results for Fiscal Year Ended December 31, 2024 and Launches DOTS MPS for Cell Culture Biopharma Market BIOPROCESSING OPERATIONS: 24% REVENUE GROWTH DRIVEN BY NEWLY LAUNCHED PRODUCTS OPERATIONAL EFFICIENCIES CUT TOTAL NET LOSSES BY 29% LAUNCHED NEW STATE OF THE ART VIVID WORKSTATION Investor Call to be held Tuesday, April 1st at 11:00 a.m. Eastern Time BOHEMIA, N.Y., March 31, 2025 (GLOBE NEWSWIRE) -- Scientific Industries, Inc. (OTCQB: SCND), a life sciences tool provider, and a developer of digitally simplified bioprocessing products, today r...

 PRESS RELEASE

Scientific Industries to Host Third Quarter 2024 Financial Results Inv...

Scientific Industries to Host Third Quarter 2024 Financial Results Investor Call on November 15, 2024 Investor Call to be held at 11:00 AM Eastern Time BOHEMIA, N.Y., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Scientific Industries, Inc. (OTCQB: SCND), a life sciences tool provider, and a developer of digitally simplified bioprocessing products, announced today it plans file the Form 10Q on November 14, 2024, for its third quarter financial results ended September 30, 2024, and will issue a press release reporting its third quarter 2024 results before the market open on November 15, 2024. The...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch